Vascular

The latest sourced reporting on Vascular from Dementias Today: dated, and plain about what the evidence does and does not show.

The chart is the patient now, and software has started reading it

A narrative review published on October 20 inventories where generative AI already touches Alzheimer's work. The uses furthest along are the ones no family ever sees: synthetic notes, phenotype mining from visit records, and drafted summaries. None of it has been tested in a live clinic.

Leuven will give healthy people an inflammation, then a memory test

A triple-blind trial at UZ Leuven randomises colon-release short-chain fatty acid capsules against placebo, then injects every volunteer with bacterial endotoxin and measures what happens to working memory, inhibition and task switching. It is a cause test in a field built mostly on correlations.

The Notebook Against the Questionnaire

Nine Italian memory clinics signed up to test whether a structured daily diary of behaviour beats standard care at lightening the load on families. Three years after the trial was registered, the results have not appeared.

Pilot Trial: App-Guided Care Plans Tied to Fewer Behavioral Symptoms in Dementia

A small randomized trial of 36 caregiver-dyads in South Korea found that a mobile app translating caregiver-logged behavior into individualized, nonpharmacological activity suggestions was associated with lower overall behavioral and psychological symptoms, less agitation and depression, better nighttime sleep efficiency, and higher caregiver confidence, researchers reported.

The Shock That Hurt More Because It Was Dreaded

In a Taipei scanner, 31 healthy adults were given the same electric jolt over and over. What changed how much it hurt was not how reliable their expectation was, but how much feeling it carried. For anyone thinking about pain and dementia, that difference matters.

The interviewer with all the time in the world

At a cognitive neurology clinic, a voice AI ran the long history-taking interview while patients waited for their testing. A peer-reviewed SIGDIAL 2026 paper reports what it caught, and what it still cannot tell anyone.

Brain scans show two routes to placebo pain relief are not the same

A pooled analysis of brain-scan data from 409 people finds that words alone and words paired with conditioning change pain-related brain activity in overlapping but partly different ways, a distinction researchers say matters for how future placebo-based protocols are designed and tested.

The Drug That Speaks to the Body Through the Brain

A widely used diabetes medicine shifted the molecular profile of old mice across heart, muscle, blood and brain. The signal ran through the hypothalamus, and it looked strikingly like the effect of blocking mTOR. This is mouse biology, not a dementia treatment.

Trial Tests Whether Telling Volunteers the Truth Can Blunt Nocebo Pain

A Dutch laboratory trial found that openly telling healthy volunteers a device could not hurt them, paired with a symptom-reversing procedure, eased artificially induced pain sensitivity as well as or better than concealing that information. The method has not been tested in patients, older adults, or anyone with a dementia.

Larger Trial Finds Dementia Caregiver App Eases Distress, Not Symptom Severity

A 262-caregiver randomized trial of WeCareAdvisor, the web app that turns a caregiver's plain-language account of a behavior into a tailored, physician-shareable plan, found a modest but statistically significant drop in caregiver distress by three months. Two of its three prespecified primary measures, confidence and the behaviors themselves, showed no significant difference between groups.

In Mice, the Room Did Half of Morphine's Work

A circuit-mapping study in mice found that a context paired with morphine later produced about half the drug's own pain relief, with the brain releasing its own opioids. A commentary in Current Biology says it is time to rethink what morphine's numbers in trials actually measure, including in studies of pain and agitation in dementia.

Chest-Worn Sensor Data Links Erratic Bedtime Timing to Dementia Risk

An analysis of the long-running ARIC cohort found that sleep measures pulled from a chest-worn heart monitor, including how much bedtime shifted night to night, tracked with later dementia diagnoses in older adults who wore the device for roughly two weeks in 2016 and 2017.

The Questionnaire That Asks the Caregiver, Not the Chart

A memory clinic team at the University of Virginia drafted a short survey to gauge how ready a care partner feels to plan ahead. The instrument exists on paper. It has not yet been given to a single caregiver in a validation study.

A Light in the Eye, a Week on the Wrist

At a Copenhagen memory clinic, a handheld torch and seven days of motion sensors were asked to forecast the next year of Alzheimer's disease. Neither one asked the patient to remember anything.

Your Brain Guesses First, Then Blurs the Details

A lab study combining EEG, pupil tracking and behavioral testing found that when a sensory event matched what people expected, they judged its location faster, but recalled the exact spot less precisely, a pattern the researchers say reveals two separate brain processes, not one.

A Machine Is Listening to the Daughter Now

Across four hospitals and 70 clinics in Hawaii, an ambient AI scribe drafted more than 25,000 real visit notes in three months. It gave clinicians back time. Whether a caregiver's account arrives intact in the note is a question nobody has asked yet.

Exeter's Dementia Policy Unit Wins Two More Years, and a Wider Brief

The National Institute for Health and Care Research has extended its Policy Research Unit at the University of Exeter with 2 million pounds and two extra years, stretching its mandate past dementia and neurodegeneration to cover more of the neurological conditions families live with.

The shadow by the door belongs to nobody

DemMA, published in the Findings of ACL 2026, puts a simulated person with dementia in the chair so trainees can practise the conversation: nine subtypes, nonverbal cues, 2,709 synthetic dialogues, and not one real patient in the data.

PAHO Finds Long-Term Care Policy Has Outpaced Financing Across the Americas

A regional midterm review of the UN Decade of Healthy Aging finds that the share of countries in the Americas with a national long-term-care policy jumped from 61 percent to 88 percent since 2020, but the money and services to make those policies real have not kept pace, with direct consequences for how dementia care gets funded and staffed.

Taiwan Cohort Splits GLP-1's Dementia Benefit: Real, but Not for Alzheimer's

A propensity-matched study of more than 21,000 Taiwanese adults with type 2 diabetes found GLP-1 receptor agonists nearly halved the risk of an overall dementia diagnosis compared with long-acting insulin, but the benefit vanished when Alzheimer's disease and vascular dementia were analyzed on their own.